Biopol Chemicals IPO GMP is currently one of the most searched topics among SME IPO investors. Market participants are actively tracking the grey market premium (GMP) to gauge the listing performance and demand for this public issue.
Biopol Chemicals IPO is a book build issue of ₹31.26 crores, consisting entirely of a fresh issue of 0.29 crore shares. The company aims to utilize the proceeds for business expansion, working capital requirements, and general corporate purposes.
In this article, we cover Biopol Chemicals IPO GMP today, issue details, price band, lot size, allotment date, listing date, and FAQs.
Biopol Chemicals IPO Overview
Biopol Chemicals Limited is engaged in manufacturing and supplying specialty chemicals catering to diverse industrial applications. With rising demand from multiple sectors, the company is expanding its production capacity and strengthening its market presence through this IPO.
Biopol Chemicals IPO Key Details
Particulars
Details
IPO Type
Book Build Issue
Issue Size
₹31.26 Crores
Fresh Issue
0.29 Crore Shares
Face Value
₹10 per share
Price Band
₹102 to ₹108 per share
Lot Size
1,200 shares
Retail Minimum Investment
₹2,59,200
HNI Minimum Investment
₹3,88,800
Listing Exchange
NSE SME
Biopol Chemicals IPO Dates
- IPO Opening Date: February 6, 2026
- IPO Closing Date: February 10, 2026
- Basis of Allotment: February 11, 2026
- Refund Initiation: February 12, 2026
- Shares Credited to Demat: February 12, 2026
- Tentative Listing Date: February 13, 2026
Biopol Chemicals IPO GMP Today (Grey Market Premium)
Biopol Chemicals IPO GMP indicates the premium at which the company’s shares are trading in the unofficial grey market before listing. GMP helps investors estimate the expected listing gains.
📌 Latest Biopol Chemicals IPO GMP today will be updated regularly on Finowings.
Why IPO GMP Matters?
- Shows investor demand
- Indicates expected listing price
- Helps in short-term decision making
- Reflects market sentiment
Note: IPO GMP is unofficial and speculative. Investors should not rely solely on GMP while making investment decisions.
Biopol Chemicals IPO Price Band & Lot Size
The price band for Biopol Chemicals IPO is fixed at ₹102 to ₹108 per share.
Investment Details
- Retail Minimum Lot: 2 lots (2,400 shares)
- Retail Investment: ₹2,59,200 (at ₹108)
- HNI Minimum Lots: 3 lots (3,600 shares)
- HNI Investment: ₹3,88,800
Objectives of Biopol Chemicals IPO
The company plans to utilize the IPO proceeds for:
- Expansion of manufacturing capacity
- Working capital requirements
- General corporate purposes
- Business growth initiatives
Should You Invest in Biopol Chemicals IPO?
Biopol Chemicals operates in a niche specialty chemical segment with rising demand. Factors like improving financial performance, industry growth, and SME market momentum make this IPO worth tracking. However, investors should always analyze:
- Company fundamentals
- Financial growth
- Industry outlook
- IPO valuation
- IPO GMP trend
before investing.
Biopol Chemicals IPO GMP – FAQs
1. What is Biopol Chemicals IPO GMP today?
Biopol Chemicals IPO GMP today refers to the grey market premium at which the shares are trading before listing. You can check the live GMP updates on Finowings.
2. What is the Biopol Chemicals IPO opening date?
The IPO opens for subscription on February 6, 2026.
3. What is the closing date of Biopol Chemicals IPO?
The issue closes on February 10, 2026.
4. What is the price band of Biopol Chemicals IPO?
The price band is ₹102 to ₹108 per share.
5. What is the minimum investment required for retail investors?
Retail investors need to invest a minimum of ₹2,59,200 for 2,400 shares.
6. When is the Biopol Chemicals IPO listing date?
The tentative listing date is February 13, 2026 on NSE SME.
7. Is Biopol Chemicals IPO a good investment?
The IPO looks promising based on industry growth and market demand, but investors should evaluate financials, business model, and IPO GMP trends before applying.
Conclusion
Biopol Chemicals IPO GMP is generating strong interest among SME IPO investors. With a reasonable issue size, clear growth strategy, and increasing sector demand, this IPO could attract healthy subscription. However, smart investors should always combine GMP trends with fundamental analysis before investing.